Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary InterventionKenichi Tsujita, Hisao Ogawa, Toshiyuki Matsumura et al.|Journal of the American College of Cardiology|2015Cited by 449
Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) studyMasanobu Ishii, Naohiro Komura, Kenshi Yamanaga et al.|European Heart Journal - Quality of Care and Clinical Outcomes|2017Cited by 74